N-(2-Benzoylphenyl)-L-tyrosine PPARγ agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety
JL Collins, SG Blanchard, GE Boswell…
Index: Journal of Medicinal Chemistry, , vol. 41, # 25 p. 5037 - 5054
Full Text: HTML
Citation Number: 127
Abstract
... Journal of Medicinal ... We now report the expanded structure−activity relationship around the phenyl alkyl ether moiety by pursuing both a classical medicinal chemistry approach and a solid-phase chemistry approach for analogue synthesis. ... Chemistry. Solution-Phase Chemistry. ...
Related Articles:
[Umape, Prashant G.; Patil, Vikas S.; Padalkar, Vikas S.; Phatangare, Kiran R.; Gupta, Vinod D.; Thate, Abhinav B.; Sekar, Nagaiyan Dyes and Pigments, 2013 , vol. 99, # 2 p. 291 - 298]
[Culbertson; Domagala; Peterson; Bongers; Nichols Journal of Heterocyclic Chemistry, 1987 , vol. 24, # 6 p. 1509 - 1520]
[Journal of Medicinal Chemistry, , vol. 41, # 4 p. 602 - 617]
[Katritzky, Alan R.; Kirichenko, Nataliya; Rogovoy, Boris V.; Kister, Jeremy; Tao, Hui Synthesis, 2004 , # 11 p. 1799 - 1805]
[Synthetic Communications, , vol. 38, # 23 p. 4076 - 4096]